• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

E2F1促进头颈部鳞状细胞癌的发生并作为一种预后生物标志物。

E2F1 Promotes the Occurrence of Head and Neck Squamous Cell Carcinoma and Serves as a Prognostic Biomarker.

作者信息

Wang Jinhang, Cui Zifeng, Hei Naiheng, Yang Qian, Peng Shixiong

机构信息

Department of Stomatology, The Second Hospital of Shijiazhuang, Huaxi Road 53, Shijiazhuang, 050051, Hebei, China.

Department of Stomatology, The Fourth Hospital of Hebei Medical University, Jiankang Road 12, Shijiazhuang, 050000, Hebei, China.

出版信息

Appl Biochem Biotechnol. 2025 Feb;197(2):1258-1279. doi: 10.1007/s12010-024-05097-w. Epub 2024 Nov 20.

DOI:10.1007/s12010-024-05097-w
PMID:39565537
Abstract

Head and neck squamous cell carcinoma (HNSCC) is a common malignant tumor occurring in various sites such as the oral cavity, pharynx, larynx, and nasal cavity. This study aimed to explore the biological functions and prognostic value of E2F transcription factor 1 (E2F1) in HNSCC. Transcriptome and single-cell sequencing (scRNA-seq) data of HNSCC patients were analyzed using data from The Cancer Genome Atlas (TCGA) and Gene Expression Omnibus (GEO). All samples were divided into high and low expression groups based on the expression levels of E2F1. A risk model was constructed based on Lasso-Cox regression, and the differences between the two groups in terms of prognosis were explored. The scRNA-seq data of HNSCC samples were analyzed using the Seurat package to identify cell types. AUCell was used to score different types of cells, and subsequently, the interaction pathways between the high-scoring cell population and other cell populations were explored using the CellChat package. The expression level of E2F1 in tumor tissues was higher than that in normal tissues, which was confirmed by in vitro experiments. Analysis of transcriptome data from TCGA revealed significant differences in overall survival (OS) between the high and low expression groups. Prognostic genes were selected based on DEGs between the two groups, and a risk model was constructed. Subsequently, a nomogram model was constructed based on clinical factors and risk scores, which exhibited good predictive performance. The expression landscape of prognostic genes in different cell types was explored using scRNA-seq data of HNSCC samples. Dendritic cell populations were identified as high-scoring cell populations, and the pathways of interaction between this cell population and other cell populations were explored. We identified E2F1 as an independent prognostic factor closely associated with the prognosis and immune response of HNSCC.

摘要

头颈部鳞状细胞癌(HNSCC)是一种常见的恶性肿瘤,发生于口腔、咽、喉和鼻腔等多个部位。本研究旨在探讨E2F转录因子1(E2F1)在HNSCC中的生物学功能和预后价值。利用来自癌症基因组图谱(TCGA)和基因表达综合数据库(GEO)的数据,分析了HNSCC患者的转录组和单细胞测序(scRNA-seq)数据。根据E2F1的表达水平将所有样本分为高表达组和低表达组。基于套索-考克斯回归构建风险模型,并探讨两组之间的预后差异。使用Seurat软件包分析HNSCC样本的scRNA-seq数据,以识别细胞类型。使用AUCell对不同类型的细胞进行评分,随后,使用CellChat软件包探索高分细胞群体与其他细胞群体之间的相互作用途径。肿瘤组织中E2F1的表达水平高于正常组织,体外实验证实了这一点。对TCGA转录组数据的分析显示,高表达组和低表达组之间的总生存期(OS)存在显著差异。根据两组之间的差异表达基因(DEG)选择预后基因,并构建风险模型。随后,基于临床因素和风险评分构建列线图模型,该模型具有良好的预测性能。利用HNSCC样本的scRNA-seq数据探索不同细胞类型中预后基因的表达图谱。树突状细胞群体被确定为高分细胞群体,并探索了该细胞群体与其他细胞群体之间的相互作用途径。我们确定E2F1是一个与HNSCC的预后和免疫反应密切相关的独立预后因素。

相似文献

1
E2F1 Promotes the Occurrence of Head and Neck Squamous Cell Carcinoma and Serves as a Prognostic Biomarker.E2F1促进头颈部鳞状细胞癌的发生并作为一种预后生物标志物。
Appl Biochem Biotechnol. 2025 Feb;197(2):1258-1279. doi: 10.1007/s12010-024-05097-w. Epub 2024 Nov 20.
2
Evaluating H2BC9 as a potential diagnostic and prognostic biomarker in head and neck squamous cell carcinoma.评估H2BC9作为头颈部鳞状细胞癌潜在的诊断和预后生物标志物。
Eur J Med Res. 2025 Jan 27;30(1):54. doi: 10.1186/s40001-025-02301-3.
3
Six Glycolysis-Related Genes as Prognostic Risk Markers Can Predict the Prognosis of Patients with Head and Neck Squamous Cell Carcinoma.六个与糖酵解相关的基因作为预后风险标志物可预测头颈部鳞状细胞癌患者的预后。
Biomed Res Int. 2021 Feb 10;2021:8824195. doi: 10.1155/2021/8824195. eCollection 2021.
4
Integrative single cell transcriptomic analysis reveals 3p deletion associated tumor microenvironment and chemoresistance in head and neck squamous cell carcinoma.综合单细胞转录组分析揭示头颈部鳞状细胞癌中与3p缺失相关的肿瘤微环境和化疗耐药性。
Sci Rep. 2025 Mar 10;15(1):8224. doi: 10.1038/s41598-025-92078-6.
5
E2F expression profiling-based subtypes in head and neck squamous cell carcinoma: clinical relevance, prognostic implications, and personalized therapy.基于E2F表达谱的头颈部鳞状细胞癌亚型:临床相关性、预后意义及个性化治疗
World J Surg Oncol. 2025 Apr 24;23(1):157. doi: 10.1186/s12957-025-03808-z.
6
Integrated analysis of single-cell RNA-seq and bulk RNA-seq unravels the molecular feature of tumor-associated neutrophils of head and neck squamous cell carcinoma.单细胞RNA测序与批量RNA测序的综合分析揭示了头颈部鳞状细胞癌肿瘤相关中性粒细胞的分子特征。
BMC Cancer. 2025 May 1;25(1):821. doi: 10.1186/s12885-025-14179-9.
7
A pyroptosis-related lncRNA signature predicts prognosis and immune microenvironment in head and neck squamous cell carcinoma.一种与焦亡相关的长链非编码RNA特征可预测头颈部鳞状细胞癌的预后和免疫微环境。
Int Immunopharmacol. 2021 Dec;101(Pt B):108268. doi: 10.1016/j.intimp.2021.108268. Epub 2021 Oct 20.
8
Seven Immune-Related Genes' Prognostic Value and Correlation with Treatment Outcome in Head and Neck Squamous Cell Carcinoma.七种免疫相关基因在头颈部鳞状细胞癌中的预后价值及其与治疗结果的相关性
Mediators Inflamm. 2023 Apr 20;2023:8533476. doi: 10.1155/2023/8533476. eCollection 2023.
9
Overexpression of TPD52L2 in HNSCC: prognostic significance and correlation with immune infiltrates.TPD52L2 在头颈部鳞状细胞癌中的过表达:预后意义及与免疫浸润的相关性。
BMC Oral Health. 2024 Oct 7;24(1):1191. doi: 10.1186/s12903-024-04977-1.
10
CCDC71L as a novel prognostic marker and immunotherapy target via lipid metabolism in head and neck squamous cell carcinoma.CCDC71L作为头颈部鳞状细胞癌中通过脂质代谢的新型预后标志物和免疫治疗靶点。
J Stomatol Oral Maxillofac Surg. 2024 Dec;125(6):101799. doi: 10.1016/j.jormas.2024.101799. Epub 2024 Feb 16.

引用本文的文献

1
E2F expression profiling-based subtypes in head and neck squamous cell carcinoma: clinical relevance, prognostic implications, and personalized therapy.基于E2F表达谱的头颈部鳞状细胞癌亚型:临床相关性、预后意义及个性化治疗
World J Surg Oncol. 2025 Apr 24;23(1):157. doi: 10.1186/s12957-025-03808-z.

本文引用的文献

1
Cell cycle regulation of the psoriasis associated gene CCHCR1 by transcription factor E2F1.由转录因子 E2F1 调控银屑病相关基因 CCHCR1 的细胞周期。
PLoS One. 2023 Dec 21;18(12):e0294661. doi: 10.1371/journal.pone.0294661. eCollection 2023.
2
CDK5 promotes apoptosis and attenuates chemoresistance in gastric cancer via E2F1 signaling.细胞周期蛋白依赖性激酶5通过E2F1信号通路促进胃癌细胞凋亡并减弱其化疗耐药性。
Cancer Cell Int. 2023 Nov 21;23(1):286. doi: 10.1186/s12935-023-03112-4.
3
Transcription Factor E2F1 Enhances Hepatocellular Carcinoma Cell Proliferation and Stemness by Activating GINS1.
转录因子 E2F1 通过激活 GINS1 增强肝癌细胞的增殖和干性。
J Environ Pathol Toxicol Oncol. 2024;43(1):79-90. doi: 10.1615/JEnvironPatholToxicolOncol.2023048594.
4
Circulating low density neutrophils are associated with resistance to anti-PD1 immunotherapy in squamous head and neck cancer.循环中低水平密度的中性粒细胞与头颈部鳞状细胞癌对 PD-1 免疫治疗的耐药性相关。
Head Neck. 2023 Dec;45(12):3075-3085. doi: 10.1002/hed.27536. Epub 2023 Oct 4.
5
Head and neck cancer treatment in the era of molecular medicine.分子医学时代的头颈部癌症治疗。
Adv Cancer Res. 2023;160:205-252. doi: 10.1016/bs.acr.2023.03.004. Epub 2023 Apr 12.
6
Expression of CD44 in Head and Neck Squamous Cell Carcinoma-An Study.CD44在头颈部鳞状细胞癌中的表达——一项研究
Glob Med Genet. 2023 Aug 16;10(3):221-228. doi: 10.1055/s-0043-1772459. eCollection 2023 Sep.
7
H1-antihistamine use and head and neck cancer risk in type 2 diabetes mellitus.H1 抗组胺药的使用与 2 型糖尿病患者头颈部癌症风险。
Oncol Res. 2023 Mar 1;31(1):23-34. doi: 10.32604/or.2022.028449. eCollection 2023.
8
Targeted therapy for head and neck cancer: signaling pathways and clinical studies.头颈部癌症的靶向治疗:信号通路与临床研究。
Signal Transduct Target Ther. 2023 Jan 16;8(1):31. doi: 10.1038/s41392-022-01297-0.
9
Reviewing the epidemiology of head and neck cancer: definitions, trends and risk factors.头颈部癌症的流行病学回顾:定义、趋势和危险因素。
Br Dent J. 2022 Nov;233(9):780-786. doi: 10.1038/s41415-022-5166-x. Epub 2022 Nov 11.
10
Head and neck cancer explained: an overview of management pathways.头颈部癌症解读:管理路径概述。
Br Dent J. 2022 Nov;233(9):721-725. doi: 10.1038/s41415-022-5199-1. Epub 2022 Nov 11.